Amalgamated Bank’s MaxCyte MXCT Stock Holding History

Amalgamated Bank’s Portfolio MXCT Stock Details MXCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-3,177	Closed	-$5K	–	2372
2025 Q4	$5K	Sell	3,177 -471	-13%	-$752	﹤0.01%	2724
2025 Q3	$6K	Hold	3,648	–	–	﹤0.01%	2683
2025 Q2	$8K	Hold	3,648	–	–	﹤0.01%	2538
2025 Q1	$10K	Buy	3,648 +345	+10%	+$1.36K	﹤0.01%	2377
2024 Q4	$14K	Hold	3,303	–	–	﹤0.01%	2281
2024 Q3	$13K	Hold	3,303	–	–	﹤0.01%	2329
2024 Q2	$13K	Hold	3,303	–	–	﹤0.01%	2313
2024 Q1	$14K	Sell	3,303 -5,009	-60%	-$23.5K	﹤0.01%	2291
2023 Q4	$39K	Sell	8,312 -983	-11%	-$3.83K	﹤0.01%	2356
2023 Q3	$29K	Hold	9,295	–	–	﹤0.01%	2482
2023 Q2	$43K	Sell	9,295 -141	-1%	-$648	﹤0.01%	2390
2023 Q1	$47K	Sell	9,436 -1,951	-17%	-$9.61K	﹤0.01%	2333
2022 Q4	$62K	Hold	11,387	–	–	﹤0.01%	2335
2022 Q3	$74K	Hold	11,387	–	–	﹤0.01%	2288
2022 Q2	$54K	Sell	11,387 -2,535	-18%	-$12.5K	﹤0.01%	2432
2022 Q1	$97K	Sell	13,922 -1,114	-7%	-$7.61K	﹤0.01%	2206
2021 Q4	$153K	Buy	+15,036	New	+$161K	﹤0.01%	2007

Other funds holding MXCT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CFM

Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return

Vitruvian Partners London, United Kingdom $201M AUM 10.44% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Mudita Advisors London, United Kingdom $490M AUM 66.64% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BFM

Brooklands Fund Management London, United Kingdom $88.9M AUM

Amalgamated Bank's MXCT Position: Q1 2026 in Review

Amalgamated Bank sold out of MaxCyte (MXCT) in Q1 2026, closing a stake of 3,177 shares — an estimated $5K sold.

Amalgamated Bank first reported a position in MXCT in Q4 2021 and held it in 17 quarters. The position peaked at $153K in Q4 2021. 131 funds tracked by Wall St. Rank hold MXCT as of Q1 2026.

Amalgamated Bank reported no remaining MaxCyte position as of Q1 2026 after selling out during the quarter.
Amalgamated Bank sold 3,177 MaxCyte shares in Q1 2026, an estimated $5K.
Amalgamated Bank first reported a position in MaxCyte in Q4 2021 and held it in 17 quarters.
Amalgamated Bank's MaxCyte position peaked at $153K in Q4 2021.
131 funds tracked by Wall St. Rank held MaxCyte as of Q1 2026.

Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.